Completed NA INTERVENTIONAL 2-arm NCT02480400

The Effect of Patient and Investigator Expectation on the Efficacy of Escitalopram in the Treatment Depression

The Effect of Patient and Investigator Expectation on the Efficacy of Escitalopram in the Treatment of Patients With Major Depressive Disorder.

Sponsor: Abarbanel Mental Health Center

Conditions Major Depressive Disorder

Interventions Escitalopram

Updated 5 times since 2017 Last updated: Jun 22, 2015 Started: Jun 30, 2010 Primary completion: Jun 30, 2012 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Major Depressive Disorder and is currently completed. Abarbanel Mental Health Center leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abarbanel Mental Health Center
H. Lundbeck A/S

Data source: Abarbanel Mental Health Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bat Yam, Israel